HEMO could break up from hereCorrection could be complete here and this would be the bottom of the channel from the start of this move up. Targets are still well above the 20p region, a great place to start accumulating. If it breaks down the Y wave should end in the 7.7-7.9p region. I dont see that coming based on dropping vol
−6.69 M GBP
0.00 GBP
3.79 M
About HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG)
Sector
Industry
CEO
Vladislav Sandler
Website
Headquarters
London
Founded
2013
ISIN
GB00BQVXM815
FIGI
BBG00BDKH4D5
HemoGenyx Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of a suite of products to address current problems associated with the treatment of blood disorders such as cancers and autoimmune diseases, with bone marrow, or hematopoietic stem cell, transplants, and with viral infections. It operates through the United Kingdom and United States geographical segments. The company was founded by Alexis M. Sandler and Vladislav Sandler in 2012 and is headquartered in London, the United Kingdom.
HEMO - in move to wave 3Massive winner today Hemogenyx (HEMO) moved 55% in 1.5h before market close on the news drop of working closely and in agreement with Eli Lilly. The correction has been clearly completed and there were already signs of this impulse up with the sub wave 1 and then sub wave 2 correction days ago. The
Hemogenyx has much more in this bull runFrom the 7,5p range this will burst off towards 15p previous top target. The news of the collaboration with GlobalCo is reinforced and is confirmed to be a positive collaboration based on expected outcome. We expect something materialised out of it in 3 months. Therefore the upside potential is rema
Hemogenyx will pump nextI see 5th leg of the Wave 3 is still missing, touched this trendline and expected to pump more.
News are due potential is big as always, but more importantly buyers are lining up, Selling volume is constantly declining on dropping price which means accumulation and a rocket sign. Multibag potential
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of HEMO is 183.5 GBX — it has decreased by −0.14% in the past 24 hours. Watch HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) stocks are traded under the ticker HEMO.
HEMO stock has risen by 7.68% compared to the previous week, the month change is a −3.70% fall, over the last year HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) has showed a −71.72% decrease.
HEMO reached its all-time high on Aug 26, 2020 with the price of 6,155.0 GBX, and its all-time low was 160.0 GBX and was reached on Mar 19, 2025. View more price dynamics on HEMO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HEMO stock is 4.99% volatile and has beta coefficient of 1.77. Track HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) stock price on the chart and check out the list of the most volatile stocks — is HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) there?
Today HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) has the market capitalization of 7.50 M, it has increased by 2.37% over the last week.
Yes, you can track HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) financials in yearly and quarterly reports right on TradingView.
No, HEMO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 27, 2025, the company has 22 employees. See our rating of the largest employees — is HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) on this list?
Like other stocks, HEMO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) stock shows the sell signal. See more of HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.